Tavaborole
- Product NDC
- 72763-201
- 11-digit product format
- 727630201
- Labeler code
- 72763
- Product ID
- 72763-201_e6c4d2f8-070c-4a81-9242-f2edca9b846f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tavaborole
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- Estreno Pharma, LLC
- Application
- ANDA211963
- Marketing category
- ANDA
- Marketing start
- 2021-02-04
- Marketing end
- 0000-00-00
- Substance
- TAVABOROLE
- Active strength
- 44 mg/mL
- Pharmacologic classes
- Oxaborole Antifungal [EPC],Protein Synthesis Inhibitors [MoA],Boron Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72763-201-10 | 72763020110 | 1 BOTTLE in 1 CARTON (72763-201-10) > 10 mL in 1 BOTTLE | 1 bottle | 2021-02-04 | 0000-00-00 | No | No | Current |